gene expression profiles of Tal1 mutants and wild type embryos, we find that that expression of claudin 5, a component of endothelial tight junctions, is dramatically down-regulated in Tal1-deficient embryos. Consistent with a defect in tight junction formation, localization of junctional components is disorganized in the Tal1-deficient endocardium. Therefore, we propose that However, Hes1 deficient mice also display a transformation of the bile duct and stomach epithelium to pancreatic cell types, but it is unclear if it acts as a Notch target in this process.
We present a systematic analysis of Notch1 activation using an antibody specific for the cleaved intracellular fragment of the receptor from late streak stages (e7.5) to e12.5 in the mouse embryo. Notch1 is activated throughout the endoderm and mesoderm at e7.5 and can be found in subsets of all three germ layers at other extracellular molecules with pyrophosphate or phosphodiester bonds are also substrates for ENPPs, and that these enzymes are involved in wide variety of physiological events attributed to signaling through specific receptors for purinergic derivatives and/or lysophospholipids which include lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P). Previously, we have reported that enpp4 and enpp6 expressions were specifically detectable in pronephros during Xenopus development (Mass etal., 2009 ). ENPP6 is a choline-specific glycerophosphodiester phosphodiesterase, with lysophospholipase C activity towards lysophosphatidylcholine. However, little is known about the substrate specificity and enzyme activity of ENPP4. In this study, we investigate functional roles of enpp4 and enpp6 in Xenopus pronephros development. Gain-of-function of enpp4 by mRNA microinjections resulted in enlarged and ectopic pronephros formation.
Point mutation in the catalytic domain of enpp4 abolished these phenotypes, indicating that enzyme activities of ENPP4 are responsible for these phenotypes. Translational inhibition of enpp4 by morpholino oligonucleotide (MO) microinjections cause reduced and absent pronephros. MO microinjections of enpp4 also inhibited expression of early pronephros marker genes, lim1 and pax8, suggesting involvement of enpp4 into early steps of pro-S170
